Treating to hypertension targets

Heart

Volumn 90, Issue SUPPL. 4, 2004, Pages

  McKerracher, A ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; CLINICAL TRIAL; CONFERENCE PAPER; CONSULTATION; DATA ANALYSIS; DIASTOLIC BLOOD PRESSURE; GENERAL PRACTICE; HEALTH SURVEY; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

EID: 2442711328     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2004.037614     Document Type: Conference Paper

References (5)

1. Ramsay LE, Williams B, Johnston GD, et al. British Hypertension Society guidelines for hypertension management 1999: summary. BMJ 1999;319:630-5.
2. Primatesta P, Brookes M, Poulter NR. Improved hypertension management and control: results from the health survey for England 1998. Hypertension 2001;38:827-32.
3. Sever PS, Dahlof B, Poulter NR, et al. Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian cardiac outcomes trial. ASCOT investigators. J Hypertens 2001;19:1139-47.
4. Brown MJ, Cruickshank JK, Dominiczak AF, et al. Executive Committee, British Hypertension Society. Better blood pressure control: how to combine drugs. J Hum Hypertens 2003;17:81-6.
5. Rouse A, Marshall T. The extent and implications of sphygmomanometer calibration error in primary care. J Hum Hypertens 2001;15:587-91.